Evaluating Payment to Participate in Research: Ethical and Regulatory Issues
Navigating research compliance often means addressing unseen challenges. Explore strategies to identify blind spots and strengthen oversight frameworks.
Education
Addressing Decentralized Pre-Enrollment Challenges for Sites and Site Networks
Addressing Decentralized Pre-Enrollment Challenges for Sites and Site Networks With continued consolidation and a move to decentralization in the research
Budget Negotiation 101
Navigating research compliance often means addressing unseen challenges. Explore strategies to identify blind spots and strengthen oversight frameworks.
Patient-centric Clinical Trials: Evolving Strategies for Engagement and Retention
In the ever-evolving world of clinical research, patient engagement has become a critical focus for pharmaceutical companies seeking to
Onboarding & Training for Clinical Research Professionals
In this webinar, Miranda Schramm, Director of Training at Advarra, covers strategies for new hires joining the clinical trial industry.
Regulatory Pathways: When to Submit a 505(b)(2) or an ANDA
Navigating research compliance often means addressing unseen challenges. Explore strategies to identify blind spots and strengthen oversight frameworks.
The Role of AI in Clinical Research: Opportunities and Ethical Challenges
Artificial intelligence (AI) is rapidly transforming multiple industries, including clinical research. While AI offers enormous potential to improve processes
Empowering Patients Through Education and Advocacy in Cancer Care
In the evolving landscape of healthcare, the role of the patient has shifted from a passive recipient of care
The IND Journey Phase I – Navigating Success
Navigating research compliance often means addressing unseen challenges. Explore strategies to identify blind spots and strengthen oversight frameworks.
2022 Trends in Clinical Trials: Innovations, Participant-centricity, and Decentralization
In 2022, clinical research evolves with lessons from COVID-19, leading to new study designs, participant engagement, and decentralized trial technologies.
Didn’t Expect That to Happen: Events That Must be Reported Promptly to the IRB
Learn what events need to be reported to the IRB after study approval and explore scenarios to help evaluate potentially reportable events.
Considerations for Transitioning from Paper to eSource
Switching from paper to eSource in clinical trials enhances data accuracy, reduces errors, and boosts organization, offering more efficient study management.